ISMP
ISMP
Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP
ISMP
ISMP Facebook

Updated: ISMP's List of High-Alert Medications

From the August 9, 2007 issue

Based on a 2007 practitioner survey and review by ISMP and other medication safety experts, ISMP’s List of High-Alert Medications has been updated (see the PDF version of the newsletter for a list). Additions to the list include: epoprostenol (Flolan) IV, oxytocin IV, promethazine IV, and sterile water for injection, inhalation, and irrigation (excluding pour bottles) in containers of 100 mL or more. Warfarin, heparin, low-molecular-weight heparin, thrombolytics, and glycoprotein IIb/IIIa inhibitors were moved to a new category, antithrombotic agents, to which Factor Xa inhibitors and direct thrombin inhibitors were added. Amiodarone and lidocaine were also moved to a new category, anti-arrhythmics IV. Nesiritide was removed from the list due to a significant decline in use.

Click here to to see the list.

Resources
Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Subscribe
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Long Term Care
Consumer
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2017 Institute for Safe Medication Practices. All rights reserved

 
ISMP
ISMP